Zhengye Biotechnology Holding Ltd received a notice from NASDAQ on May 20, 2025, for failing to file its Form 20-F by the due date of May 15, 2025, indicating non-compliance with listing rules. This event is significant from an equity investor perspective, suggesting potential operational concerns.